Evidence map›Paper›PMID 40634546›Full record

ArticleScientific reports2025

InterPAD is a database of drug-drug interaction between phytochemicals and anticancer drugs.

Aili Zhang, Xueni Sun, Qibiao Wu, Haiyang Jiang, Lihui Xu, Quan Gao, Zijing Yang, Sisi Zhu, Xinbing Sui

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Aili Zhang *State Key Laboratory of Quality Research in Chinese Medicines, Faculty of Chinese Medicine, Macau University of Science and Technology, Macau, People's Republic of China.
Xueni Sun *School of Pharmacy, Hangzhou Normal University, Hangzhou, 311121, Zhejiang, People's Republic of China.
Qibiao WuState Key Laboratory of Quality Research in Chinese Medicines, Faculty of Chinese Medicine, Macau University of Science and Technology, Macau, People's Republic of China.
Haiyang JiangSchool of Pharmacy, Hangzhou Normal University, Hangzhou, 311121, Zhejiang, People's Republic of China.
Lihui XuSchool of Pharmacy, Hangzhou Normal University, Hangzhou, 311121, Zhejiang, People's Republic of China.
Quan GaoState Key Laboratory of Quality Research in Chinese Medicines, Faculty of Chinese Medicine, Macau University of Science and Technology, Macau, People's Republic of China.
Zijing YangSchool of Pharmacy, Hangzhou Normal University, Hangzhou, 311121, Zhejiang, People's Republic of China.
Sisi ZhuSchool of Pharmacy, Hangzhou Normal University, Hangzhou, 311121, Zhejiang, People's Republic of China.
Xinbing SuiState Key Laboratory of Quality Research in Chinese Medicines, Faculty of Chinese Medicine, Macau University of Science and Technology, Macau, People's Republic of China. suilab@hznu.edu.cn.

Funding

National Natural Science Foundation of China 82104207
6 · The paper itself

Abstract

The plant kingdom is a crucial source of potential medicines, with medicinal plants playing a significant role, they have been used to treat various diseases, including cancer. Phytochemicals have emerged as promising candidates for enhancing conventional cancer treatment strategies, particularly in addressing the persistent challenges associated with such therapies. For a long time, combined therapy has been widely adopted to overcome the limitations of monotherapies. To optimize therapeutic outcomes, it is crucial to understand the mechanisms underlying the interactions between phytochemicals and conventional drugs. Based on the above, we have developed a database named InterPAD, which serves as a valuable resource to retrieve detailed information on the interactions between phytochemicals and anticancer drugs. It offers insights into their mechanisms of action and therapeutic effects, thereby facilitating a deeper understanding of how these phytochemicals can be effectively integrated into modern cancer treatment protocols. A total of 1,055 interactions involving 331 phytochemicals and 244 anticancer drugs were meticulously reviewed and manually curated from the original publications into the InterPAD database. Additionally, InterPAD curates from 680 medicinal plants, providing detailed phytochemicals-related plant information. The database also includes 619 regulatory molecules and 74 cancer types, sourced from other databases, to elucidate cancer-specific molecular mechanism and therapeutic effects. To our knowledge, InterPAD is the first comprehensive database to investigate the synergistic or antagonistic interactions of phytochemicals with drugs across various cancer types. It uniquely highlights the biological effects of phytochemicals-based anticancer interactions through the framework of "multiple-regulatory molecules and multiple-signaling pathways", providing insights into their molecular mechanisms. This resource serves as a valuable tool for advancing research and improving cancer treatment strategies. InterPAD is accessible at: https://bddg.hznu.edu.cn/interpad/ .

Indexed as

Antineoplastic AgentsAntineoplastic Agents, PhytogenicDatabases, FactualNeoplasmsPhytochemicalsDrug InteractionsHumansPlants, MedicinalAntineoplastic AgentsAntineoplastic Agents, PhytogenicPhytochemicalsAnticancer drugDrug interactionMechanisms of actionMedicinal plantPhytochemicalTherapeutic effect

Identifiers

PMID40634546
PMCPMC12241595

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.